Literature DB >> 21910879

Bronchus-associated lymphoid tissue lymphoma stage IV with subsequent histologic transformation to an aggressive lymphoma: A case report.

Rajeev Swarup1.   

Abstract

INTRODUCTION: Extranodal marginal B-cell lymphoma of bronchus-associated lymphoid tissue is a rare entity accounting for less than 1% of all lymphomas. We report a case of a low-grade bronchus-associated lymphoid tissue lymphoma stage IV with transformation to an aggressive large B-cell lymphoma. CASE
PRESENTATION: A 59-year-old African-American man was incidentally found to have a bronchus-associated lymphoid tissue lymphoma involving the bilateral lower lobes of his lungs. In addition, bone marrow involvement was discovered. His course was indolent with only some mild respiratory symptoms. He received single agent treatment with rituximab. No evidence of progression was seen at the end of receiving this regimen. Two years after treatment our patient presented with B symptoms. Imaging now showed significant increase in the size of the lung masses with cavitation of the right lower lobe mass. A repeat transbronchial biopsy suggested transformation to an aggressive diffuse large B-cell lymphoma.
CONCLUSION: This case illustrates a rare bronchus-associated lymphoid tissue lymphoma stage IV with histologic transformation to an aggressive lymphoma. In addition, this rare case of transformation presented as a cavitary lesion.

Entities:  

Year:  2011        PMID: 21910879      PMCID: PMC3179457          DOI: 10.1186/1752-1947-5-455

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  15 in total

1.  Cavitary lung mass representing primary pulmonary malignant lymphoma with initial diagnosis by fine needle aspiration biopsy.

Authors:  B T Collins
Journal:  Acta Cytol       Date:  2001 Sep-Oct       Impact factor: 2.319

2.  Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.

Authors:  Shahid Ahmed; Steven J Kussick; Anita K Siddiqui; Tawfiqul A Bhuiya; Arfa Khan; Stephen Sarewitz; Harry Steinberg; Cristina P Sison; Kanti R Rai
Journal:  Eur J Cancer       Date:  2004-06       Impact factor: 9.162

Review 3.  Transformation of indolent B-cell lymphomas.

Authors:  Silvia Montoto; Jude Fitzgibbon
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients.

Authors:  J F Cordier; E Chailleux; D Lauque; M Reynaud-Gaubert; A Dietemann-Molard; J C Dalphin; F Blanc-Jouvan; R Loire
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

5.  Bronchus-associated lymphoid tissue in human lung: correlation of hyperplasia with chronic pulmonary disease.

Authors:  H J Meuwissen; M Hussain
Journal:  Clin Immunol Immunopathol       Date:  1982-05

6.  Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis.

Authors:  A Sato; H Hayakawa; H Uchiyama; K Chida
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

7.  Bronchus-associated lymphoid tissue lymphomas.

Authors:  Konstantinos Arnaoutakis; Thein H Oo
Journal:  South Med J       Date:  2009-12       Impact factor: 0.954

Review 8.  Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma.

Authors:  Shahid Ahmed; Anita Karim Siddiqui; Kanti R Rai
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

9.  [Primary pulmonary lymphoma presenting as a pulmonary mass with cavitation].

Authors:  C Martínez Rivera; M Bonnin Vilaplana; C Simón Adiego; A Palacín Forgué; J Puig Zuza; I Sampablo Lauro
Journal:  Arch Bronconeumol       Date:  2004-02       Impact factor: 4.872

10.  Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma.

Authors:  Hisao Imai; Noriaki Sunaga; Kyoichi Kaira; Osamu Kawashima; Noriko Yanagitani; Koji Sato; Yoshio Tomizawa; Takeshi Hisada; Tamotsu Ishizuka; Junko Hirato; Ryusei Saito; Takashi Nakajima; Masatomo Mori
Journal:  Intern Med       Date:  2009-03-02       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.